Upstate Researcher Receives Leukemia & Lymphoma Society Scholar Award
Dr. Golam Mohi, an Associate Professor in the Department of Pharmacology at SUNY Upstate Medical University, has been awarded the Leukemia and Lymphoma Society Scholar Award this year. Dr. Mohi’s laboratory is studying the molecular and signaling events controlling hematopoietic stem cell (HSC) function and determining how oncogenic mutations give rise to myeloprolifierative neoplasms (MPNs), a group of blood cancers characterized by excessive production of different types of blood cells. The Leukemia and Lymphoma Society Scholar award will support his study titled JAK2 in Hematopoietic Stem Cell Maintenance and Myelorpoliferative Neoplasms. Findings from Dr. Mohi’s laboratory studies are leading to a better understanding of how a mutation of the JAK2 gene may cause MPNs and would have significant clinical implications in determining therapies for MPNs.
Core Research Facilities
SUNY Upstate has many core research facilities of service to the entire university. More >
Upstate Medical University will share a $12.1 million with two other upstate New York institutions as they work to develop a new medical treatment for multiple sclerosis.
Upstate’s Burk Jubelt, MD, professor of neurology, microbiology and immunology, is the project’s principal investigator.